METHUSELAH ARCHIVE SOURCES / CONVERSATION-NMN-NAD-RESVERATROL-EVIDENCE-2026

Can supplements containing NMN, NAD+ and resveratrol really slow ageing? Here's what the evidence says

secondary literature · 2026
type:secondary literature
year:2026
citation:Elbediwy, Ahmed, and Nadine Wehida. Can supplements containing NMN, NAD+ and resveratrol really slow ageing? Here's what the evidence says. The Conversation (US edition), 20 May 2026.
LINK
https://theconversation.com/can-supplements-containing-nmn-nad-and-resveratrol-really-slow-ageing-heres-what-the-evidence-says-282524
SUMMARY
Evidence review by two Kingston University senior lecturers (Elbediwy in Cancer Biology & Clinical Biochemistry, Wehida in Genetics and Molecular Biology), published under The Conversation's editorial model (academic authors, editor-reviewed, disclosed expertise). Concludes human trials show NMN/NR raise NAD+-related blood markers but that 'recent reviews have not found convincing evidence that NMN or NR preserve muscle mass or function in older adults,' with outcomes closer to everyday aging (strength, cognition, frailty, biological age) 'much less clear'; that resveratrol has poor oral bioavailability and human trials 'have not shown convincing evidence that resveratrol slows ageing'; and that 'the marketing often turns "this affects a process associated with ageing" into "this supplement will keep you young".' Byline, credentials, and date confirmed directly on the fetched page.
NOTES

The case’s present-day, established-expert-source critique of the currently marketed NMN and resveratrol supplements, satisfying the active-enterprise sourced-critique standard’s requirement for a documented, current assessment of the products still being sold, independent of any company or practitioner in the case.